Question
In the Electrophile-first approach for covalent drug discovery, the starting point for the design of the covalent inhibitor is......
A.
В.
C.
D.
The Protein of interest.
The non-covalent ligand.
The warhead.
All of the above
A.
В.
C.
D.
The Protein of interest.
The non-covalent ligand.
The warhead.
All of the above
Answers
GPT-4o mini
In the Electrophile-first approach for covalent drug discovery, the starting point for the design of the covalent inhibitor is typically **The warhead**. This approach involves designing a reactive electrophile (warhead) that can form a covalent bond with a specific nucleophilic site on the target protein, thus providing a mechanism for selectivity and activity.
So, the answer is:
**C. The warhead.**
So, the answer is:
**C. The warhead.**
Related Questions
describe a two treatment reversal design involving the effect of drug X and drug Y on hyperactivity.
Which discovery of James Cook affected WA the most?
*
1 point
The discovery of Nootka Bay.
The d...
is there any single gene disorder mentioned in here
Horizon Discovery () is using CRISPR technolog...
What was George H.W. Bush’s approach to issues such as education and drug reform?
Bush advocated...